Applications of 1-Methyl-3-Ethylimidazolium Hexafluorophosphate in Industrial Manufacturing

1-Methyl-3-ethylimidazolium hexafluorophosphate serves as a high-performance ionic liquid, widely adopted in advanced chemical process industries. Its unique physicochemical properties enable downstream manufacturers to achieve process efficiencies and enhanced product profiles in regulated sectors. We supply this material in strict accordance with dedicated application demands, ensuring traceability, batch consistency, and documentation for compliance audits.

1. Electrolytes for High-Performance Lithium-ion Batteries

Battery manufacturers incorporate this ionic liquid as a key component within non-aqueous electrolytes, improving ionic conductivity and operational stability at elevated temperatures. Its electrochemical window and low volatility allow producers to formulate cells offering higher safety margins, especially in large-format and high-rate charge-discharge battery designs. Integration often involves co-solvent systems and engineered separator wettability for consistent lithium plating and suppression of side reactions.

Industry compliance standards

• UN Manual of Tests and Criteria for Battery Transport Safety
• IEC 62660-2:2018 for lithium-ion battery safety
• ISO 12405 for lithium-ion battery system testing
• RoHS and REACH Annex XVII Restrictions

Typical usage ratio

• 5–20% (w/w) as secondary electrolyte; adjusted according to cell design, separator material, and target operating temperature

Downstream process integration

• Added during dry-room electrolyte blending under inert atmosphere
• Direct mixing with standard organic carbonate electrolytes (e.g., EC/DEC mixtures)
• Final filling into assembled cell under controlled pressure and vacuum conditions

Final product types

• Automotive lithium-ion battery packs (passenger EVs, commercial ESS)
• Stationary grid storage modules
• High-power lithium polymer batteries for power tools

2. Solvent and Electrolyte Component in Electrochemical Metal Plating

Industrial electroplating lines use this compound as a solvent or bath additive to improve deposit grain structure, uniformity, and efficiency, notably in the plating of aluminum, copper, and rare metals on specialized substrates. Its low coordination and negligible vapor pressure facilitate low-temperature metal ion transfer, reducing energy costs and waste effluent volumes. Plating bath engineers adjust the ionic liquid concentration to match target substrate area and cathodic current densities.

Industry compliance standards

• ISO 4527 for electrodeposited coatings
• ASTM B633 for electrodeposited coatings of zinc on iron and steel
• REACH regulation (EC No 1907/2006)
• OSHA 29 CFR 1910.1200 for workplace chemical safety

Typical usage ratio

• 10–40% (v/v) in electrolyte bath composition; fine-tuned per metal salt solubility and plating current profile

Downstream process integration

• Prepared in agitation tanks with pre-dissolved metal salts and conductivity boosters
• Continuous monitoring of bath ionic composition using inline FT-IR or conductivity sensors
• Direct transfer via piping to plating baths; periodic replenishment cycles scheduled

Final product types

• Microelectronic connectors with gold or copper plating
• Automotive aluminum alloy trim components
• High-purity copper foils for printed circuit boards

3. Green Solvent in Pharmaceutical API Synthesis

Pharmaceutical companies apply the ionic liquid as a reusable solvent in the synthesis of complex active pharmaceutical ingredients (APIs), particularly where high selectivity, reduced side-product formation, and simplified separation are critical. Its chemical inertness and ability to dissolve both polar and non-polar substances contribute to consistency in sterically demanding catalytic steps. Process engineers validate its removal and recovery in compliance with drug trace ionic residue requirements to ensure batch-to-batch safety.

Industry compliance standards

• ICH Q7: GMP for Active Pharmaceutical Ingredients
• 21 CFR Parts 210/211 (cGMP for finished pharmaceuticals)
• USP Chapter <467> Residual Solvents
• EMA Guideline on Setting Health Based Exposure Limits

Typical usage ratio

• 20–60% (v/v), mainly influenced by catalyst solubility and API isolation requirements

Downstream process integration

• Charged to jacketed reactors after API precursor addition
• Solvent regeneration lines installed post-reaction with vacuum distillation
• Final product washing with pharmacopeial-grade solvents to minimize ionic residuals

Final product types

• Antiviral and oncology API intermediates
• Chiral drug molecules produced via selective hydrogenation
• Steroid and heterocyclic pharmaceutical actives

4. Catalytic Media in Cellulose Biomass Processing

Producers of second-generation biofuels and platform chemicals utilize the ionic liquid as a dissolution and catalytic medium to process lignocellulosic feedstocks. Its ability to disrupt crystalline cellulose structures increases enzymatic accessibility, thereby enhancing yield in saccharification and fermentation steps. System operators optimize ratios to balance viscosity, cellulose loading, and downstream enzymatic activity, targeting industrial scale throughput with closed-loop solvent recovery.

Industry compliance standards

• EN 15367 for solid biofuels process control
• ISO 9001 for process management systems
• US EPA Renewable Fuel Standard (RFS2) quality criteria
• EU Waste Framework Directive (2008/98/EC)

Typical usage ratio

• 30–70% (w/w) ionic liquid to dry biomass, depending on feedstock type and desired depolymerization extent

Downstream process integration

• Initial addition to fiber pretreatment vessels before enzyme hydrolysis
• Semi-batch or continuous cycle reactors with in situ dilution capability
• Ionic liquid extracted, filtered, and recycled for multiple cycles via cross-flow membrane separation

Final product types

• Cellulosic bioethanol
• Fermentable sugars for bioplastic production
• Lignin-derived aromatic chemicals